Back to top
more

Clorox (CLX)

(Delayed Data from NYSE)

$162.77 USD

162.77
994,723

+0.07 (0.04%)

Updated Nov 7, 2024 04:00 PM ET

After-Market: $162.84 +0.07 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 15% (37 out of 251)

Industry: Soap and Cleaning Materials

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Rajani Lohia headshot

5 Soaps & Cleaning Materials Stocks Showing Potential Amid Hardships

by Rajani Lohia

The soap and cleaning materials industry battles headwinds from elevated logistics, input and manufacturing costs. Innovation, digital growth and brand building are likely to drive players like PG, RBGLY, HENKY, CHD and CLX.

Clorox (CLX) Tops Q1 Earnings & Sales Estimates, Retains View

by Zacks Equity Research

Clorox's (CLX) Q1 results reflect gains from brand strength, strong execution, cost savings and a favorable price mix despite lower volumes.

Clorox (CLX) Beats Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Clorox (CLX) delivered earnings and revenue surprises of 27.40% and 3.26%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

What Awaits The Estee Lauder Companies (EL) in Q1 Earnings?

by Zacks Equity Research

The Estee Lauder Companies (EL) Q1 performance will likely reflect adverse impacts from record inflation and supply chain disruptions. That said, strength in online sales is a breather.

Nu Skin (NUS) Queued for Q3 Earnings: Things to Consider

by Zacks Equity Research

Nu Skin's (NUS) Q3 performance will likely reflect continued economic uncertainty, prolonged COVID-associated factors, unfavorable currency rates and geopolitical conflicts.

Kellogg's (K) Q3 Earnings Upcoming: Here's All You Should Note

by Zacks Equity Research

Kellogg's (K) third-quarter 2022 results are likely to reflect gains from the company's revenue growth management actions, whereas cost inflation and supply-chain bottlenecks are likely to have been a concern.

Sysco's (SYY) Q1 Earnings Upcoming: Key Factors to Note

by Zacks Equity Research

Sysco's (SYY) first-quarter fiscal 2023 results are likely to reflect gains from the Recipe for Growth program and a diversified model, whereas high costs might have been a concern.

Service Corporation (SCI) to Report Q3 Earnings: Things to Note

by Zacks Equity Research

Service Corporation's (SCI) third-quarter 2022 performance will likely reflect the adverse impact of rising inflationary pressure. Strength in the funeral segment has been an upside.

Factors Likely to Influence Molson Coors' (TAP) Earnings in Q3

by Zacks Equity Research

Molson Coors' (TAP) Q3 results are likely to reflect gains from positive pricing and favorable brand and channel mix stemming from portfolio premiumization and reduced on-premise channel restrictions.

Here's Why Clorox (CLX) is Poised to Top Q1 Earnings Estimates

by Zacks Equity Research

Clorox's (CLX) first-quarter fiscal 2023 results are likely to reflect gains from the IGNITE strategy and pricing actions, whereas elevated inflation concerns are likely to have acted as deterrents.

Colgate-Palmolive (CL) Q3 Earnings Meet Estimates

by Zacks Equity Research

Colgate-Palmolive (CL) delivered earnings and revenue surprises of 0% and 0.97%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Can Colgate (CL) Beat Q3 Earnings Estimates Amid Cost Woes?

by Zacks Equity Research

Colgate's (CL) Q3 results are expected to reflect gains from strong demand, brand strength, innovation and digital growth, offset by higher raw material and logistic costs.

Clorox (CLX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research

Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Brand Strength to Aid Colgate (CL) Despite High Inflation

by Zacks Equity Research

Despite rising raw material costs, Colgate's (CL) robust innovation and expansion plans are likely to drive growth in the long term.

Should First Trust Value Line Dividend ETF (FVD) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for FVD

Why Is Clorox (CLX) Up 5.9% Since Last Earnings Report?

by Zacks Equity Research

Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Is First Trust Value Line Dividend ETF (FVD) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for FVD

Tirthankar Chakraborty headshot

Beat the Market the Zacks Way: Walt Disney (DIS), AmerisourceBergen (ABC), C.H. Robinson Worldwide (CHRW) in Focus

by Tirthankar Chakraborty

Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our accomplishments from last week.

Taiwan Semiconductor Manufacturing and The Clorox Company have been highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Taiwan Semiconductor Manufacturing and The Clorox Company are part of Zacks Bull and Bear of the Day article.

Derek Lewis headshot

Bear of the Day: The Clorox Company (CLX)

by Derek Lewis

Overwhelmingly negative estimate revisions paint a grim picture for the company in the short term.

Clorox (CLX) Falls on Q4 Earnings & Sales Miss, Bleak View

by Zacks Equity Research

Clorox's (CLX) Q4 results reflect the impacts of lower shipments, higher tax rate and continued costs headwinds related to elevated manufacturing and logistics costs, and higher commodity costs.

Clorox (CLX) Lags Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Clorox (CLX) delivered earnings and revenue surprises of -2.11% and 2.95%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Clorox (CLX) Readies for Q4 Earnings: What's in the Cards?

by Zacks Equity Research

Clorox's (CLX) fourth-quarter fiscal 2022 results are likely to reflect gains from the IGNITE strategy and pricing actions, whereas elevated cost concerns are likely to have affected profits.

Procter & Gamble (PG) Q4 Earnings Miss Estimates

by Zacks Equity Research

P&G (PG) delivered earnings and revenue surprises of -1.63% and 0.63%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Clorox (CLX) Q4 Earnings Preview: What's in the Cards?

by Zacks Equity Research

Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.